fluconazole has been researched along with Infections, Staphylococcal in 25 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this patient with severe, chronic polymicrobial spine infection with epidural abscess and CSF fistula due to multidrug-resistant organisms, the cure was achieved with long-term antimicrobial specific therapy with quinupristin-dalfopristin (50 days) and linezolid (100 days) with mild side effects." | 7.73 | Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid. ( Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M, 2006) |
| "Fluconazole prophylaxis was accompanied by a significant decrease in both the rate and number of days of bacterial infections as well as co-infections." | 5.40 | Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates. ( Abou Jaoude, R; DeBari, VA; Lamacchia, M; McClure, D; Morel, C; Zauk, A, 2014) |
| " In this patient with severe, chronic polymicrobial spine infection with epidural abscess and CSF fistula due to multidrug-resistant organisms, the cure was achieved with long-term antimicrobial specific therapy with quinupristin-dalfopristin (50 days) and linezolid (100 days) with mild side effects." | 3.73 | Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid. ( Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M, 2006) |
| "A 49-year-old Japanese woman treated with oral corticosteroids, methotrexate, and infliximab for malignant rheumatoid arthritis was admitted because of fever and low back pain." | 3.73 | Infectious myositis involving the piriformis in a patient with rheumatoid arthritis. ( Fujinaga, H; Oda, S; Takahashi, K, 2006) |
| " Combined with good oral bioavailability (F = 42." | 1.43 | Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. ( Chen, F; Di, H; Lan, L; Li, J; Lu, Y; Sheng, C; Wang, X; Wang, Y; Wei, H; Xiao, Q; Xu, Y; Zhang, L; Zhu, J, 2016) |
| "One patient developed Fusarium infection." | 1.40 | Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. ( Adil, SN; Ali, N; Shaikh, MU, 2014) |
| "Fluconazole prophylaxis was accompanied by a significant decrease in both the rate and number of days of bacterial infections as well as co-infections." | 1.40 | Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates. ( Abou Jaoude, R; DeBari, VA; Lamacchia, M; McClure, D; Morel, C; Zauk, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venkatesh, MP | 1 |
| Pham, D | 1 |
| Fein, M | 1 |
| Kong, L | 1 |
| Weisman, LE | 1 |
| Wang, Y | 4 |
| Damu, GL | 1 |
| Lv, JS | 1 |
| Geng, RX | 1 |
| Yang, DC | 1 |
| Zhou, CH | 1 |
| Sharma, V | 1 |
| Singh, G | 1 |
| Kaur, H | 1 |
| Saxena, AK | 1 |
| Ishar, MP | 1 |
| Chen, F | 3 |
| Di, H | 2 |
| Xu, Y | 3 |
| Xiao, Q | 2 |
| Wang, X | 2 |
| Wei, H | 3 |
| Lu, Y | 3 |
| Zhang, L | 2 |
| Zhu, J | 3 |
| Sheng, C | 1 |
| Lan, L | 3 |
| Li, J | 3 |
| Ni, S | 1 |
| Li, B | 1 |
| Liu, Y | 1 |
| Chen, W | 1 |
| Qiu, X | 1 |
| Li, X | 2 |
| Liu, W | 2 |
| Hu, L | 1 |
| Lin, D | 1 |
| Wang, M | 1 |
| Zheng, X | 1 |
| Mao, F | 1 |
| Sheng, B | 1 |
| Chen, Y | 1 |
| Sun, L | 1 |
| Xu, P | 1 |
| Han, B | 1 |
| Yin, J | 1 |
| Li, T | 1 |
| Guan, H | 1 |
| Chen, S | 1 |
| Wang, Q | 1 |
| Li, C | 1 |
| Li, S | 1 |
| Jiang, X | 1 |
| Wang, P | 1 |
| He, Q | 1 |
| Xiao, W | 1 |
| Yang, H | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Ali, N | 1 |
| Adil, SN | 1 |
| Shaikh, MU | 1 |
| Abou Jaoude, R | 1 |
| Zauk, A | 1 |
| Morel, C | 1 |
| McClure, D | 1 |
| Lamacchia, M | 1 |
| DeBari, VA | 1 |
| Li, H | 1 |
| Zhang, C | 1 |
| Liu, P | 1 |
| Gao, Y | 1 |
| Sun, S | 1 |
| Kong, EF | 1 |
| Kucharíková, S | 1 |
| Van Dijck, P | 1 |
| Peters, BM | 1 |
| Shirtliff, ME | 1 |
| Jabra-Rizk, MA | 1 |
| Goff, TA | 1 |
| Kanakaris, NK | 1 |
| Kesler, KA | 1 |
| Langdorf, MI | 1 |
| Burns, MJ | 1 |
| Parikh, SV | 1 |
| Memon, N | 1 |
| Echols, M | 1 |
| Shah, J | 1 |
| McGuire, DK | 1 |
| Keeley, EC | 1 |
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Khan, DA | 1 |
| Rodríguez-Adrián, LJ | 1 |
| King, RT | 1 |
| Tamayo-Derat, LG | 1 |
| Miller, JW | 1 |
| Garcia, CA | 1 |
| Rex, JH | 1 |
| Zhao, Q | 1 |
| Liao, J | 1 |
| Qin, H | 1 |
| Wang, J | 1 |
| Marroni, M | 1 |
| Tinca, M | 1 |
| Belfiori, B | 1 |
| Altobelli, G | 1 |
| Malincarne, L | 1 |
| Papili, R | 1 |
| Stagni, G | 1 |
| Oda, S | 1 |
| Fujinaga, H | 1 |
| Takahashi, K | 1 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 1 |
| Benca, J | 1 |
| Krcmery, V | 1 |
| Bartlett, ST | 1 |
| Vassallo, J | 1 |
| Galizia, AC | 1 |
| Cuschieri, P | 1 |
| Nouwen, JL | 1 |
| van Belkum, A | 1 |
| de Marie, S | 1 |
| Sluijs, J | 1 |
| Wielenga, JJ | 1 |
| Kluytmans, JA | 1 |
| Verbrugh, HA | 1 |
3 reviews available for fluconazole and Infections, Staphylococcal
| Article | Year |
|---|---|
Purulent pericarditis: report of 2 cases and review of the literature.
Topics: Aneurysm, Infected; Aortic Aneurysm, Thoracic; Bacterial Infections; Candida glabrata; Candidiasis; | 2009 |
Cutaneous drug reactions.
Topics: Animals; Drug Eruptions; Female; Fluconazole; Hernia, Inguinal; Herniorrhaphy; Humans; Methicillin-R | 2012 |
Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Corynebacterium Infections; Female; Flu | 2003 |
22 other studies available for fluconazole and Infections, Staphylococcal
| Article | Year |
|---|---|
Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.
Topics: Animals; Animals, Newborn; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Microbial | 2007 |
Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Drug Design; Fluoroquinolones; Fungi | 2012 |
Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Methicillin-Resista | 2012 |
Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzofurans; Biological Av | 2016 |
Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN).
Topics: Alkanes; Anti-Bacterial Agents; Antifungal Agents; Dose-Response Relationship, Drug; Drug Discovery; | 2016 |
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Bacterial; Ether-A-Go-Go Potassi | 2017 |
Antifungal Treatment Aggravates Sepsis through the Elimination of Intestinal Fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dysbiosis; Feces; Fluconazole; F | 2021 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Cath | 2014 |
Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates.
Topics: Antifungal Agents; Chemoprevention; Coagulase; Female; Fluconazole; Humans; Incidence; Infant; Infan | 2014 |
In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Calcium; Candida albicans; Candidiasis; Coinfect | 2015 |
Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
Topics: Animals; Candida albicans; Candidiasis, Oral; Coinfection; Disease Models, Animal; Female; Fluconazo | 2015 |
Management of infected non-union of the proximal femur: a combination of therapeutic techniques.
Topics: Adult; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Cements; Candidia | 2014 |
Opioid Dependent Malingerer with Self-Induced Sepsis.
Topics: Analgesics, Opioid; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Echinocandins; Emergenc | 2016 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
Clinical evaluation of ERCP and naobiliary drainage for biliary fungal infection--a report of five cases of severe combined bacterial and fungal infection of biliary tract.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Biliary Tract Diseases; Candid | 2005 |
Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Cerebrospinal Fluid; Combined Modality Therapy; Cross I | 2006 |
Infectious myositis involving the piriformis in a patient with rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Antirheum | 2006 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Pancreatic transplantation after thirty years: still room for improvement.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Pancreas Transplantation; Posto | 1996 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination | 1996 |
Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department.
Topics: Air Microbiology; Antibiotic Prophylaxis; Bacteriological Techniques; Catheterization, Central Venou | 1998 |